California Public Employees Retirement System Has $2.84 Million Holdings in Omnicell, Inc. (NASDAQ:OMCL)

California Public Employees Retirement System increased its position in shares of Omnicell, Inc. (NASDAQ:OMCL) by 11.7% in the 4th quarter, HoldingsChannel reports. The firm owned 75,523 shares of the company’s stock after acquiring an additional 7,902 shares during the quarter. California Public Employees Retirement System’s holdings in Omnicell were worth $2,842,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Covestor Ltd lifted its holdings in shares of Omnicell by 65.6% during the 3rd quarter. Covestor Ltd now owns 1,355 shares of the company’s stock worth $61,000 after acquiring an additional 537 shares during the period. Acadian Asset Management LLC bought a new position in shares of Omnicell in the 3rd quarter valued at $62,000. Neo Ivy Capital Management acquired a new position in shares of Omnicell during the 3rd quarter worth $78,000. Fifth Third Bancorp lifted its position in shares of Omnicell by 143.2% during the 3rd quarter. Fifth Third Bancorp now owns 2,230 shares of the company’s stock worth $100,000 after buying an additional 1,313 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in Omnicell by 110.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,392 shares of the company’s stock valued at $153,000 after buying an additional 1,777 shares in the last quarter. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on OMCL shares. Benchmark reissued a “buy” rating and set a $38.00 target price on shares of Omnicell in a research note on Tuesday, April 30th. Wells Fargo & Company cut their target price on shares of Omnicell from $28.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Friday, February 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Omnicell has an average rating of “Hold” and an average target price of $42.20.

Omnicell Stock Up 2.9 %

Shares of NASDAQ OMCL opened at $30.13 on Monday. The company has a 50 day simple moving average of $27.73 and a 200 day simple moving average of $31.66. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.38 and a quick ratio of 2.22. Omnicell, Inc. has a 1 year low of $25.69 and a 1 year high of $77.14. The firm has a market cap of $1.38 billion, a PE ratio of -65.50 and a beta of 0.77.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.22. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. The firm had revenue of $258.85 million during the quarter, compared to the consensus estimate of $256.00 million. On average, research analysts forecast that Omnicell, Inc. will post 0.09 EPS for the current year.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.